ProCE Banner Activity

CE / CME

Early Identification and Management of CKD: A Call to Action for PCPs

Video

On-demand webcast of expert faculty presentation and case discussion for primary care providers on the early identification and treatment management of patients with chronic kidney disease.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurses: 1.00 Nursing contact hour

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: December 11, 2023

Expiration: December 10, 2024

No longer available for credit.

Share

Faculty

Rajeev Raghavan

Rajeev Raghavan, MD, M.Ed., FASN, FACP

Program Director, HCA Kingwood Internal MedicineClinical Professor, University of Houston Fertitta Family College of MedicineAssociate Designated Institution Official, HCA Gulf Coast DivisionHCA Houston HealthcareKingwood, Texas

Chuck Vega

Chuck Vega, MD, FAAFP

Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
Director, Program in Medical Education for the Latino Community (PRIME-LC)
UC Irvine School of Medicine
Irvine, California         

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company

Target Audience

The target audience for this educational program is primary care physicians, nurse practitioners and physician associates who care for patients with or who are at risk for CKD.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of PCPs in the early screening, identification, and management of CKD

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Construct a CKD screening and follow-up plan to facilitate early identification and management of kidney disease

  • Design a medication therapy plan for cardiorenal protection in a patient with CKD, integrating guideline recommendations with expanding evidence-based treatment options and patient specific clinical characteristics

  • Employ best practices in referral and multidisciplinary management of patients with CKD

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Rajeev Raghavan, MD, M.Ed., FASN, FACP

Program Director, HCA Kingwood Internal MedicineClinical Professor, University of Houston Fertitta Family College of MedicineAssociate Designated Institution Official, HCA Gulf Coast DivisionHCA Houston HealthcareKingwood, Texas

Rajeev Raghavan, MD, M.Ed., FASN, FACP: consultant/advisor/speaker: GlaxoSmithKline.

Chuck Vega, MD, FAAFP

Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
Director, Program in Medical Education for the Latino Community (PRIME-LC)
UC Irvine School of Medicine
Irvine, California         

Chuck Vega, MD: consultant/advisor/speaker: Boehringer Ingelheim. 

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, learners must follow these steps during the period from December 11, 2023, through December 10, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page
  2. Read the target audience, learning objectives, and faculty disclosures
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

 

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.

Physician Associate Continuing Medical Education
Joint AccreditationClinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until December 10, 2024. PAs should only claim credit commensurate with the extent of their participation.